ArticleOncotarget2016

MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.

Cheng-Han Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.